# Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

> **NCT00146055** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 60 (—)

## Conditions studied

- Myeloma, Plasma-Cell
- Lymphoma, Malignant
- Myeloproliferative Disorders
- Myelodysplastic Syndromes
- Waldenstrom's Macroglobulinemia

## Interventions

- **PROCEDURE:** Reduced intensity conditioning with allogeneic transplant

## Key facts

- **NCT ID:** NCT00146055
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2004-11
- **Final completion:** 2007-10
- **Target enrollment:** 60 (—)
- **Last updated:** 2012-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146055, "Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT00146055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*